The list does not include biotechnology companies that are currently owned by, or … Country . Despite the company’s ranking as a major provider of drug access to poor nations, the company has been embroiled in several scandals regarding financial practices. The ranking is based on the medical professionals’ evaluation of the pharmaceutical companies concerning the following dimensions: quality of marketing and sales, quality of products and services, innovativeness, efficiency, transparency, accountability, ethical behavior, management quality and commercial success. GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 making it most experienced biotech and one of the world’s top research based health management and pharmaceutical companies in the world. Top pharmaceutical companies with revenue over $10 billion, List of largest pharmaceutical companies by revenue, List of largest biotechnology & pharmaceutical companies, https://johnsonandjohnson.gcs-web.com/static-files/b23c74b5-3cd3-4c2e-8c67-035aa484749f, "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results: | BioSpace", "Johnson & Johnson Reports 2018 Fourth-Quarter Results:", "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson", "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson", "Johnson & Johnson Reports 2015 Fourth-Quarter Results:", "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson", "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson", "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results:", "Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:", https://www.roche.com/dam/jcr:3bc1f151-1def-483b-868c-8bd1ef59ccc4/en/irp210204-a.pdf, https://www.roche.com/dam/jcr:e49f6995-e813-43c1-9302-c9b7d0bddbc8/en/irp200130-a.pdf, https://www.roche.com/dam/jcr:af865dfd-50fb-458b-9cac-34097db9d3ec/en/ar18e.pdf, https://www.roche.com/dam/jcr:ee2f197f-5487-4629-9e28-66b77c9cbbab/en/ar16e.pdf, https://www.roche.com/dam/jcr:9b36e11d-495c-42f5-b757-e80c4e88d793/en/gb15e.pdf, https://www.roche.com/dam/jcr:880b44a1-3fd6-4e66-bf10-f4af1e724d4d/en/gb14e.pdf, https://www.roche.com/dam/jcr:64fd6b2d-1a76-467f-badd-ab94b85b6d70/en/gb13e.pdf, https://www.roche.com/dam/jcr:3e048249-e3ce-4969-a77e-cc90d8f3fa73/en/gb12e.pdf, https://www.roche.com/dam/jcr:52174b39-feab-4210-82f6-9b8786a69ecf/en/gb11e.pdf, http://ir.sinopharmgroup.com.cn/attachment/2020091708240127219443832_en.pdf, http://ir.sinopharmgroup.com.cn/attachment/202004240816014279248723_en.pdf, http://ir.sinopharmgroup.com.cn/attachment/2019042506350100033473013_en.pdf, http://ir.sinopharmgroup.com.cn/attachment/2018042506320200033121116_en.pdf, http://ir.sinopharmgroup.com.cn/attachment/2017042106200200012785604_en.pdf, http://ir.sinopharmgroup.com.cn/attachment/201607131609541765679138_en.PDF, http://ir.sinopharmgroup.com.cn/attachment/2015041006320100032166702_en.pdf, http://ir.sinopharmgroup.com.cn/attachment/20140410061701001886801_en.pdf, http://ir.sinopharmgroup.com.cn/attachment/20130419164701001633683_en.pdf, http://ir.sinopharmgroup.com.cn/attachment/20120420064701001411060_en.pdf, https://www.bayer.com/sites/default/files/2021-02/Bayer-Annual-Report-2020.pdf, http://www.annualreport2017.bayer.com/servicepages/downloads/files/bayer_ar17_entire.pdf, http://www.annualreport2016.bayer.com/servicepages/downloads/files/bayer_ar16_entire.pdf, http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf, https://www.novartis.com/sites/www.novartis.com/files/2021-01-interim-financial-report-en.pdf, https://www.novartis.com/sites/www.novartis.com/files/q4-2019-media-release-en.pdf, https://www.novartis.com/sites/www.novartis.com/files/q4-2018-media-release-en.pdf, https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf, https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf, https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf, https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf, https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf, https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2011-en.pdf, https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2020-financial-results/, https://www.biospace.com/article/releases/merck-announces-fourth-quarter-and-full-year-2019-financial-results/?s=72, "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results", "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket", http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf, http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf, http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf, http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf, http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf, http://s21.q4cdn.com/488056881/files/doc_financials/2011/annual/form-10-k-2011.pdf, https://www.gsk.com/media/6557/fy-2020-results-announcement.pdf, https://www.gsk.com/media/5820/fy-2019-results-announcement.pdf, "GSK delivers sales, earnings and cash flow growth in 2018 - GSK", https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf, https://www.gsk.com/media/3609/annual-report-2016.pdf, https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf, https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf, https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf, https://www.gsk.com/media/2694/annual-report-2012.pdf, https://www.gsk.com/media/2696/annual-report-2011.pdf, https://investors.abbvie.com/static-files/28ec0c10-474f-4b35-9133-1518835fd31e, https://www.biospace.com/article/releases/abbvie-reports-full-year-and-fourth-quarter-2019-financial-results/?s=72, "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center", https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/Q4-results-2020, https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/Q4-results-2019, https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/press-releases/Q42018results.pdf?la=en&hash=CDCE30350F0C658C000A909535AD9AF636A93560, https://www.sanofi.com/media/Project/One-Sanofi-Web/sanofi-com/en/investors/docs/press-releases/Press_release_Q4_FY_2017.pdf, https://en.sanofi.com/Images/49288_20-F_2016.pdf, https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf, https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf, https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf, https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf, https://en.sanofi.com/Images/29804_20F_2011.pdf, https://s21.q4cdn.com/104148044/files/doc_financials/quarterly_reports/2020/BMY-Q42020-Earnings-Press-Release.pdf, https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79, "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom", "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results", "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom", "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom", "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom", "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom", https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf, https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/BristolMyersSquibb-2011-AnnualReport.pdf, https://s21.q4cdn.com/317678438/files/doc_financials/2020/q4/Q4-2020-PFE-Earnings-Release.pdf, "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS | BioSpace", https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2018/q4/Q4-2018-PFE-Earnings-Release.pdf, https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf, https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf, https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf, https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf, https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf, https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf, https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2011/financial2011.pdf, https://www.abbottinvestor.com/static-files/b225dfc0-1f17-4ff9-b8c7-c995bf7ea03e, https://www.biospace.com/article/releases/abbott-reports-fourth-quarter-2019-results-announces-strong-forecast-for-2020/?s=72, "Abbott Reports 2018 Results and Issues Strong Forecast for 2019", "Abbott Reports Fourth-Quarter 2017 Results", "Abbott Reports Fourth-Quarter 2016 Results", "Abbott Reports Fourth-Quarter 2015 Results", "Abbott Reports Fourth-Quarter 2014 Results", "Abbott Reports Fourth-Quarter and Full-Year 2013 Results", "Abbott Reports Fourth-Quarter and Full-Year 2012 Results", "Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings - FiercePharma", http://d18rn0p25nwr6d.cloudfront.net/CIK-0000097745/e8ed1418-dec6-4147-b378-48498ca8a954.pdf, https://www.biospace.com/article/releases/thermo-fisher-scientific-reports-fourth-quarter-and-full-year-2019-results/?s=72, https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2018/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2017-Results/default.aspx, https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2017/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2016-Results/default.aspx, https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2016/Thermo-Fisher-Scientific-Reports-Record-Fourth-Quarter-and-Full-Year-2015-Results/default.aspx, https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2015/Thermo-Fisher-Scientific-Reports-Strong-Fourth-Quarter-and-Full-Year-2014-Results/default.aspx, http://thermofisher.mediaroom.com/2013-01-31-Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2012-Results, https://investorrelations.medtronic.com/static-files/9a576213-cdd1-41e9-aa72-e2cbf15c1a8d, https://investorrelations.medtronic.com/static-files/da4767cb-a6c9-4716-801e-48a0a3155e1f, https://investorrelations.medtronic.com/static-files/262eb1cb-ed16-422c-b33c-d9f031105481, https://investorrelations.medtronic.com/static-files/b6508122-6f3b-473e-9638-8c8b8dc226a5, https://investorrelations.medtronic.com/static-files/5f89558e-dd8c-48ff-9645-a279cdd38460, https://investorrelations.medtronic.com/static-files/07b454a5-4517-402f-999e-e1db87ff991e, https://investorrelations.medtronic.com/static-files/bcc415af-20c5-4f19-9efa-9312bb36cf03, https://investorrelations.medtronic.com/static-files/91cd662f-ceb7-4442-8de5-43fbd51202f8, https://investorrelations.medtronic.com/static-files/35f7dd75-6583-4c3c-a731-b95fefbd9793, https://investorrelations.medtronic.com/static-files/7f6de2e5-cec2-47a2-b37e-980c66c7c478, https://www.takeda.com/48fe83/siteassets/system/investors/quarterly-announcements/fy2020/qr2020_q3_qfr_en.pdf, https://www.takeda.com/newsroom/newsreleases/2020/takeda-accelerates-transformation-solid-fy2019-results-confidence-in-fy2020-growth-momentum/, https://www.takeda.com/newsroom/newsreleases/2019/takeda-reports-fy2018-full-year-results-and-issues-fy2019-guidance/, "Takeda reports FY2017 full year results and issues FY2018 guidance", "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report", https://www.astrazeneca.com/content/dam/az/PDF/2020/full-year/Full-year_2020_results_announcement.pdf, https://www.astrazeneca.com/content/dam/az/PDF/2019/full-year/Full-year_and_Q4_2019_results_announcement.pdf, https://www.astrazeneca.com/content/dam/az/PDF/2018/full-year/Full-Year_2018_Results_announcement.pdf, https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf, https://www.astrazeneca.com/content/dam/az/PDF/Full_year_and_q4_2016_results/Full_Year_and_Q4_2016_Results_announcement.pdf, "AstraZeneca PLC fourth quarter and full year results 2014", "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca", "AstraZeneca PLC Fourth quarter and full year results 2012", "AstraZeneca PLC Fourth quarter and full year results 2011", https://investors.amgen.com/static-files/5c48bb65-ef7d-49d4-ad9f-aa8a683ba9e4, https://www.biospace.com/article/releases/amgen-reports-fourth-quarter-and-full-year-2019-financial-results/?s=72, "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results", http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1, http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1, http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1, http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1, http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1, http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTM0MzEzfENoaWxkSUQ9LTF8VHlwZT0z&t=1, http://investors.gilead.com/static-files/7227feec-53b9-4809-8181-fa1441f34f31, https://www.biospace.com/article/releases/gilead-sciences-announces-fourth-quarter-and-full-year-2019-financial-results/?s=72, "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results", https://investor.lilly.com/static-files/ff47dd65-36a8-4bec-9c5a-62c4e494c8e1, https://www.biospace.com/article/releases/lilly-reports-strong-fourth-quarter-and-full-year-2019-financial-results-updates-2020-guidance-for-pending-dermira-acquisition/?s=72, "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology", http://files.shareholder.com/downloads/LLY/5951368162x0x970018/15B962F7-AF5A-4FFA-BE13-42206D3A0820/Q4_2017_PressRelease.pdf, "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)", http://files.shareholder.com/downloads/LLY/5951368162x0x871993/5BE670A3-2B82-4876-8471-CA6BC3BD49F8/Lilly_Q4_2015_Press_Release.pdf, http://files.shareholder.com/downloads/LLY/5951368162x0x806120/8637C572-31C4-402E-A179-5E107A5366B2/Q414_Lilly_Sales_and_Earnings_Press_Release.pdf, http://files.shareholder.com/downloads/LLY/5951368162x0x721860/2DB60538-94FE-4E96-98D2-DA72CC301EA0/Q413%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf, http://files.shareholder.com/downloads/LLY/5951368162x0x631117/85679233-E13C-4FE7-9431-E97EFFDA6D5D/Q412%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf, http://files.shareholder.com/downloads/LLY/5951368162x0x538046/24A15621-7850-45EC-8E20-30535C3D9FC9/Q411_Lilly_Sales_and_Earnings_Press_Release.pdf, http://investors.danaher.com/image/4Q+2020+Danaher+Earnings+Presentation.pdf, http://investors.danaher.com/image/4Q2019+Danaher+Earnings+Presentation.pdf, http://investors.danaher.com/download/Danaher_Annual_Report_2018.pdf, http://investors.danaher.com/download/danaher_2017_annualreport.pdf, http://investors.danaher.com/download/Danaher_2016+Annual+Report.pdf, http://investors.danaher.com/download/2015+Danaher+Annual+Report.pdf, http://investors.danaher.com/download/DHR_AR_2014.pdf, http://investors.danaher.com/download/DHR_AR_2013.pdf, http://investors.danaher.com/download/DHR_AR_2012.pdf, http://investors.danaher.com/download/DHR_AR_2011.pdf, https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2020-q4/en/2020-Q4-Report-EN.pdf, https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2019-q4/en/2019-Q4-Report-EN.pdf, "Q4/FY Results of 2018 - News - Merck KGaA, Darmstadt, Germany", http://ar2016.merckgroup.com/sites/default/files/downloads/en/merck_annual_report_2016.pdf, http://ar2015.emdgroup.com/sites/default/files/downloads/emd/Merck_GB2015_EN.pdf, http://ar2014.merckgroup.com/sites/default/files/downloads/en/Merck_GB2014_EN.pdf, https://www.novonordisk.com/content/dam/nncorp/global/en/investors/irmaterial/annual_report/2021/Novo-Nordisk-Annual-Report-2020.pdf, https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2020/20200502_Financial%20statement%20Q4%202019_UK.pdf, https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2019/20190201_Financial%20statement%20Q4%202018_UK.pdf, https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2017/20170202_Financial%20statement_FY%202016_UK.pdf, "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript", "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript", "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript", "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript", http://www.novonordisk.co.uk/content/dam/Denmark/HQ/Commons/documents/Novo-Nordisk-AR-2011-en.pdf, https://investor.viatris.com/static-files/cdedc51f-115c-4a34-8134-9e7182dda6a9, https://www.ge.com/sites/default/files/ge_webcast_presentation_01262021.pdf, https://www.statista.com/statistics/277734/revenue-for-general-electric-healthcare-segment-since-2008/, http://annualreport.boehringer-ingelheim.com/fileadmin/Download-Center/BI_GB_18_en_ohne_Unterschriften.pdf, "Boehringer Ingelheim 2017 Annual Report", "Boehringer Ingelheim total revenue 2007-2017 - Statistic", https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/180f4f3673c1bef8/747507c6608d/Siemens_Healthineers-_Annual-_Report_2020.pdf, https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000006835562/12e08501046c/Siemens-Healthineers-Annual-Report-2019.pdf, https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000005904947/ef806566e5ee/Annual-Report-2018.pdf, https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf, https://www.medline.com/pages/about-us/stats-claims/, https://www.medline.com/pages/corporate-social-responsibility-2019-report/, https://www.medline.com/media/catalog/Docs/MKT/WP/CSR-2019.pdf, https://investors.bd.com/static-files/eb5a4eef-e5ef-4522-aa7b-1dfcb4df0443, https://investors.bd.com/static-files/8cc141b1-2f6d-4cd4-8d24-faabe1f14b1e, https://investors.bd.com/static-files/03dfef9f-a6e6-4d98-9b7f-39b5cee53055, https://s24.q4cdn.com/720828402/files/doc_financials/2020/q4/Teva_Q4-2020_Earnings-Presentation_Final.pdf, https://www.biospace.com/article/releases/teva-reports-fourth-quarter-and-full-year-2019-financial-results/?s=72, https://s24.q4cdn.com/720828402/files/doc_downloads/doc_financial/2018/q4/Teva-Form-10-K-2018.pdf, "Teva Reports 2017 Full Year and Fourth Quarter Financial Results", http://www.tevapharm.com/news/teva_reports_full_year_and_fourth_quarter_2016_financial_results_02_17.aspx, http://www.tevapharm.com/news/teva_reports_full_year_2015_and_fourth_quarter_financial_results_02_16.aspx, "Teva Reports Fourth Quarter and Full Year 2014 Results", http://www.tevapharm.com/news/teva_reports_fourth_quarter_and_full_year_2013_results_02_14.aspx, "Teva Reports Fourth Quarter and Full Year 2012 Results", http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTI2NDkwfENoaWxkSUQ9LTF8VHlwZT0z&t=1, https://d18rn0p25nwr6d.cloudfront.net/CIK-0000310764/2051b683-79d9-40f5-8885-ec9e1e218a3f.pdf, https://investors.stryker.com/press-releases/news-details/2020/Stryker-reports-2019-results-and-2020-outlook/default.aspx, https://s22.q4cdn.com/857738142/files/doc_financials/2018/Stryker_Annual_Report_2018.pdf, https://s22.q4cdn.com/857738142/files/doc_financials/2016/STRYKER-2016-AR.pdf, https://s22.q4cdn.com/857738142/files/doc_financials/2014/SYK_AR-14_4_29_15-FINAL.pdf, https://s22.q4cdn.com/857738142/files/doc_financials/2012/SYK-2012-AR_-03-14-13-FINAL_Single-Pages.pdf, https://ir.labcorp.com/static-files/f377837c-0676-45e4-8678-932ab01f8814, https://ir.labcorp.com/static-files/753d1464-9421-43f1-be83-d5e0be586800, http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDE2OTE0fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636873221632383468, http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MjI4ODI1fENoaWxkSUQ9LTF8VHlwZT0z&t=1, https://investors.biogen.com/static-files/e8fb597e-5179-4279-8ba1-48df48152d86, https://investors.biogen.com/static-files/ce31eed8-8862-4bec-a63f-77c0fd6e15a1, http://investors.biogen.com/static-files/c0d4fbe2-d4f2-404b-be17-19e770386d6e, "Biogen's Spinraza: Great Launch, Rough Ride", http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2016_on_Form_10K.pdf, http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2015_on_Form_10K.pdf, http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_2014_Annual_Report_Web.pdf, http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2013.pdf, http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2012.pdf, http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/2011ar.pdf, https://sw4503.swcms.net/en/business-results/inframe/main/0/teaserItems1/0/linkList/0/link/2q2020_en.pdf, https://sw4503.swcms.net/en/ir-library/business-results/inframe/main/010/teaserItems1/00/linkList/0/link/4q2019_en_v1.pdf, "Astellas Pharma Inc.
Kailer Yamamoto Ethnicity, Definition Of Best Friend Forever, Concert Radio Station, Dexamethasone In Second Trimester Pregnancy, Epl Table 2020 Latest, Trine 4: The Nightmare Prince System Requirements, Slave 1 Lego 20th Anniversary, Zombie Apocalypse Project Answers, Meteor Shower Ireland,